The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer

Published:2021-11 Issue: Volume:161 Page:141-151
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Joosten P.J.M.,de Langen A.J.,van der Noort V.,Monkhorst K.,Klomp H.M.,Veenhof A.A.F.A.,Dickhoff C.,Smit E.F.,Hartemink K.J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system;Chen;Cancer,2014

3. Rusch VW, Rice TW, Crowley J, et al. The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg 2010;139:819-821. doi: 10.1016/j.jtcvs.2010.02.013.

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

5. Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324;Blumenschein;J. Clin. Oncol.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression;Liver Cancer;2024-02-01

2. Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series;International Journal of Gynecologic Cancer;2024-01-31

3. Treatment of the Oligometastatic Patient;Interdisciplinary Cancer Research;2024

4. Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients;World Journal of Surgical Oncology;2023-11-25

5. 肺癌oligometastasesおよびoligo-recurrenceに対する外科治療の現状;Haigan;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3